company
Boston Scientific Corporation
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · device_recall2026-07-01Boston Scientific Corporation — Class II recall: Intera Oncology INTERA 3000 Hepatic Artery Infusion Pump, AP-0300H, implantable…
- fda_recall · device_recall2026-06-17Boston Scientific Corporation — Class II recall: Orca Single Use Air/Water and Suction Valves, Material Number (UPN) SUV-617-50;…
- fda_recall · device_recall2026-05-13Boston Scientific Corporation — Class II recall: LUX-Dx II Plus, Arrythmia detector and alarm, Model M312, with SERVER SW LATITUD…
- fda_recall · device_recall2026-05-13Boston Scientific Corporation — Class II recall: LUX-DX II, Arrythmia detector and alarm, Model M302, with SERVER SW LATITUDE DRA…
- fda_recall · device_recall2026-05-06Boston Scientific Corporation — Class I recall: Boston Scientific Pacemaker, Implantable Pulse Generator, Pacemaker (non- Cardia…
- fda_recall · device_recall2026-05-06Boston Scientific Corporation — Class I recall: Boston Scientific Cardiac Resynchronization Therapy (CRT)labeled as: 1. VALIT…
Frequently asked questions
- How many FDA warning letters has Boston Scientific Corporation received?
- Argus HQ has not recorded an FDA warning letter for Boston Scientific Corporation in our current dataset.
- What FDA recalls has Boston Scientific Corporation issued?
- Argus HQ has recorded 6 FDA recalls tied to Boston Scientific Corporation.
- Is Boston Scientific Corporation FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 6 recalls, and 0 approval records for Boston Scientific Corporation. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.